HMMR and cancer: Resnick et al. [168] found that a common HA receptor (CD44) was overexpressed in a number of cancers, though a link had already been noticed by Yang et al. [169], who also determined the selectivity of over-expressed hyaluronan-mediated motility receptor (RHAMM) in cancer [168,170].